Isabelle Benz-De Bretagne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Isabelle Benz-De Bretagne has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Bertil Kågedal
Department of Clinical Chemistry and Clinical Pharmacology and Department of Biomedical and Clinical Sciences, Linköping University
1 shared publication - Carl-Fredrik Mandenius
Linköping University
1 shared publication - Charlotte Salmon Gandonnière
Service de Médecine Intensive Réanimation, CHRU de Tours, Tours, France
1 shared publication - Charlotte Veyrat-Durebex
Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France
1 shared publication - Christian Robert Andres
UMR Inserm 1253 Ibrain, Université de Tours, 37032 Tours, France
1 shared publication Elisabeth Plouvier
Laboratoire de biochimie, Groupement hospitalier de l'Est francilien, Site de Meaux, France
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
Monitoring of Intensive Care Patients by a Physiology-Related GFR Method
Background: In the intensive care of critically ill patients, accurate and reliable determination of the glomerular filtration rate (GFR) is of utmost importance. We have previously used one of the most established methods for this purpose, iohexol plasma clearance measurement, in combination with a mechanistic model based on mass balances and physiological intercompartmental transport. Here, we apply this method in an intensive care unit setting to investigate its validity for estimating GFR and to interpret data from critically ill patients. Methods: In 86 patients undergoing advanced supportive care for shock, sepsis, or other severe conditions, GFR was estimated using the clearance of iohexol during 24 h after an intravenous injection. Individual iohexol plasma clearance was determined by the mass balance model. Parameters were fitted to each patient’s plasma clearance profiles to estimate GFR. The model estimates were compared with estimations using the established Bröchner–Mortensen regression approach and a maximum a posteriori Bayesian estimator. Results: Iohexol plasma disappearance was stable over the 24-h monitoring period in 80% of patients, while 20% exhibited unstable elimination profiles. In patients with stable profiles, the mechanistic model showed significant correlations with Bröchner–Mortensen estimates and the Bayesian estimator. Conclusion: This physiology-based model strengthens the determination of GFR by providing interpretable parameters linked to transport and exchange processes between plasma and extracellular volumes and urinary excretion. The model shows that short-term GFR changes can be illustrated during the plasma concentration trajectory of iohexol, and short-term GFRs can be calculated.
- 28 September 2026
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
Open AccessMonitoring of Intensive Care Patients by a Physiology-Related GFR Method
Background: In the intensive care of critically ill patients, accurate and reliable determination of the glomerular filtration rate (GFR) is of utmost importance. We have previously used one of the most established methods for this purpose, iohexol plasma clearance measurement, in combination with a mechanistic model based on mass balances and physiological intercompartmental transport. Here, we apply this method in an intensive care unit setting to investigate its validity for estimating GFR and to interpret data from critically ill patients. Methods: In 86 patients undergoing advanced supportive care for shock, sepsis, or other severe conditions, GFR was estimated using the clearance of iohexol during 24 h after an intravenous injection. Individual iohexol plasma clearance was determined by the mass balance model. Parameters were fitted to each patient’s plasma clearance profiles to estimate GFR. The model estimates were compared with estimations using the established Bröchner–Mortensen regression approach and a maximum a posteriori Bayesian estimator. Results: Iohexol plasma disappearance was stable over the 24-h monitoring period in 80% of patients, while 20% exhibited unstable elimination profiles. In patients with stable profiles, the mechanistic model showed significant correlations with Bröchner–Mortensen estimates and the Bayesian estimator. Conclusion: This physiology-based model strengthens the determination of GFR by providing interpretable parameters linked to transport and exchange processes between plasma and extracellular volumes and urinary excretion. The model shows that short-term GFR changes can be illustrated during the plasma concentration trajectory of iohexol, and short-term GFRs can be calculated.
- 13 December 2024
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 48 (3)
Homocystinuria in a 14-year-old girl with neurodevelopmental delay
- 13 December 2024
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 48 (3)
Homocystinuria in a 14-year-old girl with neurodevelopmental delay
- Open Access
- 7 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 11196
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients
Central nervous system (CNS) barrier impairment has been reported in amyotrophic lateral sclerosis (ALS), highlighting its potential significance in the disease. In this context, we aim to shed light on its involvement in the disease, by determining albumin quotient (QAlb) at the time of diagnosis of ALS in a large cohort of patients. Patients from the university hospital of Tours (n = 307) were included in this monocentric, retrospective study. In total, 92 patients (30%) had elevated QAlb levels. This percentage was higher in males (43%) than in females (15%). Interestingly, QAlb was not associated with age of onset, age at sampling or diagnostic delay. However, we found an association with ALS functional rating scale-revised (ALSFRS-r) at diagnosis but this was significant only in males. The QAlb levels were not linked to the presence of a pathogenic mutation. Finally, we performed a multivariate survival analysis and found that QAlb was significantly associated with survival in male patients (HR = 2.3, 95% CI = 1.2–4.3, p = 0.009). A longitudinal evaluation of markers of barrier impairment, in combination with inflammatory biomarkers, could give insight into the involvement of CNS barrier impairment in the pathogenesis of the disease. The gender difference might guide the development of new drugs and help personalise the treatment of ALS.
- 7 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 11196
Open AccessImplication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients
Central nervous system (CNS) barrier impairment has been reported in amyotrophic lateral sclerosis (ALS), highlighting its potential significance in the disease. In this context, we aim to shed light on its involvement in the disease, by determining albumin quotient (QAlb) at the time of diagnosis of ALS in a large cohort of patients. Patients from the university hospital of Tours (n = 307) were included in this monocentric, retrospective study. In total, 92 patients (30%) had elevated QAlb levels. This percentage was higher in males (43%) than in females (15%). Interestingly, QAlb was not associated with age of onset, age at sampling or diagnostic delay. However, we found an association with ALS functional rating scale-revised (ALSFRS-r) at diagnosis but this was significant only in males. The QAlb levels were not linked to the presence of a pathogenic mutation. Finally, we performed a multivariate survival analysis and found that QAlb was significantly associated with survival in male patients (HR = 2.3, 95% CI = 1.2–4.3, p = 0.009). A longitudinal evaluation of markers of barrier impairment, in combination with inflammatory biomarkers, could give insight into the involvement of CNS barrier impairment in the pathogenesis of the disease. The gender difference might guide the development of new drugs and help personalise the treatment of ALS.
- Open Access
- 1 February 2020
- Published by Springer Nature in Immunologic Research
- Vol. 68 (1) , 7-12
History, extensive characterization and challenge of anti-tetanus serum from World War I: exciting remnants and deceived hopes
During World War I (WWI), infectious diseases including tetanus were among the most important causes of death. Even though its efficacy was somewhat controversial before the war, tetanus antiserum played a key role in reducing the mortality of this disease. A vial of tetanus antiserum dating back from WWI, left behind on the French battlefield by the US Army, was borrowed from a private collection and opened. The serum contained within was characterized by orthogonal biochemical techniques to determine if any neutralizing IgGs could remain after 100 years of storage. In vitro analysis by Size Exclusion Chromatography and Serum Protein Electrophoresis suggested the presence of residual IgG. In spite of our hopes, these IgGs were not able to protect mice against tetanus toxin challenge in a neutralizing assay. Even though our results indicate the presence of remaining IgGs inside the serum, they were functionally disabled. These results show that obscurity alone is insufficient to protect IgGs from degradation over very long periods of time at room temperature. Highlights Tetanus antiserum found its place in the therapeutic arsenal during World War I A century-old vial of tetanus antiserum was opened for biochemical and in vivo characterization Biochemical assays revealed the presence of proteins having all the characteristics of IgGs The serum was unable to protect mice against toxinic challenge
- 1 February 2020
- Published by Springer Nature in Immunologic Research
- Vol. 68 (1) , 7-12
Open AccessHistory, extensive characterization and challenge of anti-tetanus serum from World War I: exciting remnants and deceived hopes
During World War I (WWI), infectious diseases including tetanus were among the most important causes of death. Even though its efficacy was somewhat controversial before the war, tetanus antiserum played a key role in reducing the mortality of this disease. A vial of tetanus antiserum dating back from WWI, left behind on the French battlefield by the US Army, was borrowed from a private collection and opened. The serum contained within was characterized by orthogonal biochemical techniques to determine if any neutralizing IgGs could remain after 100 years of storage. In vitro analysis by Size Exclusion Chromatography and Serum Protein Electrophoresis suggested the presence of residual IgG. In spite of our hopes, these IgGs were not able to protect mice against tetanus toxin challenge in a neutralizing assay. Even though our results indicate the presence of remaining IgGs inside the serum, they were functionally disabled. These results show that obscurity alone is insufficient to protect IgGs from degradation over very long periods of time at room temperature. Highlights Tetanus antiserum found its place in the therapeutic arsenal during World War I A century-old vial of tetanus antiserum was opened for biochemical and in vivo characterization Biochemical assays revealed the presence of proteins having all the characteristics of IgGs The serum was unable to protect mice against toxinic challenge
- 1 November 2018
- Published by JLE in Annales de biologie clinique
- Vol. 76 (6) , 609-616
Preanalytical step of urinary protein measurement: from urine sampling to preparation for analysis of the specimen
The preanalytical phase is a key step in urinary protein measurement. It is a complex step, which includes urine sampling, storage and transport to the laboratory and preparation for analysis of the specimen. It can lead to numerous errors, since urine sampling is made by the patient himself. According to different cases, the procedures for urine sampling are presented in appendix 1 to 4. The aim of the presented guidelines is to improve the preanalytical step. In addition to the sampling made by a well-informed patient, the laboratory has to optimize transport and sample preservation, according to the analytes. The 24-hour urine collection is divided into aliquots with commercially available systems. Urinary proteins are measured on samples stored without preservatives. When 24-hour urine collection is not possible, a mid-stream urine sample is the most appropriate sample for protein measurement.
- 1 November 2018
- Published by JLE in Annales de biologie clinique
- Vol. 76 (6) , 609-616
Preanalytical step of urinary protein measurement: from urine sampling to preparation for analysis of the specimen
The preanalytical phase is a key step in urinary protein measurement. It is a complex step, which includes urine sampling, storage and transport to the laboratory and preparation for analysis of the specimen. It can lead to numerous errors, since urine sampling is made by the patient himself. According to different cases, the procedures for urine sampling are presented in appendix 1 to 4. The aim of the presented guidelines is to improve the preanalytical step. In addition to the sampling made by a well-informed patient, the laboratory has to optimize transport and sample preservation, according to the analytes. The 24-hour urine collection is divided into aliquots with commercially available systems. Urinary proteins are measured on samples stored without preservatives. When 24-hour urine collection is not possible, a mid-stream urine sample is the most appropriate sample for protein measurement.